Tsumura & Co operates in the Pharmaceutical preparations sector.
In addition to historical fundamental analyses, the complete report available to purchase compares Tsumura & Co with three other
companies in this sector in Japan:
Nippon Shinyaku Co Ltd
sales of 101.45 billion Japanese Yen [US$903.90 million]
of which 86%
was Pharmaceutical Products),
KYORIN Holdings, Incorporation
(110.64 billion Japanese Yen [US$985.80 million]
of which 95%
was Pharmaceutical Business), and
Mochida Pharmaceutical Company Limited
(106.76 billion Japanese Yen [US$951.24 million]
of which 100%
was Pharmaceutical Business).
Tsumura & Co reported sales of ¥117.88 billion (US$1.05 billion)
March of 2018.
increase of 2.5%
versus 2017, when the company's sales were ¥114.95 billion.
Sales at Tsumura & Co have increased during each of the previous five years
(and since 2013, sales have increased a total of 12%).